Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honghui Zhou

Showing results (61-70 of 143) with videos related to

Pageof 15
Sort By:
Pharmaceutical Research|January 1, 2016
Deciphering the In Vivo Performance of a Monoclonal Antibody to Neutralize Its Soluble Target at the Site of Action in a Mouse Collagen-Induced Arthritis ModelWeirong Wang, Thomas S McIntosh, Xiling Jiang, et al.
Journal of Affective Disorders|March 31, 2010
Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patientsXiaobin Zhang, Zhijun Zhang, Weiwei Sha, et al.
Reproduction (Cambridge, England)|December 22, 2011
Circulating microRNAs are elevated in plasma from severe preeclamptic pregnanciesLiang Wu, Honghui Zhou, Haiyan Lin, et al.
Journal of Clinical Pharmacology|October 22, 2004
Absence of a clinically relevant interaction between etanercept and digoxinHonghui Zhou, Virginia Parks, Alain Patat, et al.
Mabs|September 24, 2020
A minimal physiologically based pharmacokinetic model to characterize colon TNF suppression and treatment effects of an anti-TNF monoclonal antibody in a mouse inflammatory bowel disease modelSongmao Zheng, Jin Niu, Brian Geist, et al.
Psychiatry Research|November 10, 2009
Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depressionXiaobin Zhang, Zhijun Zhang, Weiwei Sha, et al.
The AAPS Journal|November 30, 2013
Mechanistic pharmacokinetic/target engagement/pharmacodynamic (PK/TE/PD) modeling in deciphering interplay between a monoclonal antibody and its soluble target in cynomolgus monkeysWeirong Wang, Xiaofeng Wang, Rajitha Doddareddy, et al.
Journal of Clinical Pharmacology|November 26, 2009
Population-based exposure-efficacy modeling of ustekinumab in patients with moderate to severe plaque psoriasisHonghui Zhou, Chuanpu Hu, Yaowei Zhu, et al.
Clinical and Translational Science|October 24, 2019
Translational Model-Informed Dose Selection for a Human Positron Emission Tomography Imaging Study of JNJ-54175446, a P2X7 Receptor AntagonistYan Xu, Xin Miao, Paulien Ravenstijn, et al.
Clinical Therapeutics|December 3, 2014
Pharmacokinetic bridging approach for developing biologics-delivery devices: a case study with a golimumab autoinjectorZhenhua Xu, Stanley J Marciniak, Bart Frederick, et al.
Pageof 15

Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
Pharmaceutical Research|January 1, 2016
Deciphering the In Vivo Performance of a Monoclonal Antibody to Neutralize Its Soluble Target at the Site of Action in a Mouse Collagen-Induced Arthritis ModelWeirong Wang, Thomas S McIntosh, Xiling Jiang, et al.
Journal of Affective Disorders|March 31, 2010
Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patientsXiaobin Zhang, Zhijun Zhang, Weiwei Sha, et al.
Reproduction (Cambridge, England)|December 22, 2011
Circulating microRNAs are elevated in plasma from severe preeclamptic pregnanciesLiang Wu, Honghui Zhou, Haiyan Lin, et al.
Journal of Clinical Pharmacology|October 22, 2004
Absence of a clinically relevant interaction between etanercept and digoxinHonghui Zhou, Virginia Parks, Alain Patat, et al.
Mabs|September 24, 2020
A minimal physiologically based pharmacokinetic model to characterize colon TNF suppression and treatment effects of an anti-TNF monoclonal antibody in a mouse inflammatory bowel disease modelSongmao Zheng, Jin Niu, Brian Geist, et al.
Psychiatry Research|November 10, 2009
Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depressionXiaobin Zhang, Zhijun Zhang, Weiwei Sha, et al.
The AAPS Journal|November 30, 2013
Mechanistic pharmacokinetic/target engagement/pharmacodynamic (PK/TE/PD) modeling in deciphering interplay between a monoclonal antibody and its soluble target in cynomolgus monkeysWeirong Wang, Xiaofeng Wang, Rajitha Doddareddy, et al.
Journal of Clinical Pharmacology|November 26, 2009
Population-based exposure-efficacy modeling of ustekinumab in patients with moderate to severe plaque psoriasisHonghui Zhou, Chuanpu Hu, Yaowei Zhu, et al.
Clinical and Translational Science|October 24, 2019
Translational Model-Informed Dose Selection for a Human Positron Emission Tomography Imaging Study of JNJ-54175446, a P2X7 Receptor AntagonistYan Xu, Xin Miao, Paulien Ravenstijn, et al.
Clinical Therapeutics|December 3, 2014
Pharmacokinetic bridging approach for developing biologics-delivery devices: a case study with a golimumab autoinjectorZhenhua Xu, Stanley J Marciniak, Bart Frederick, et al.
Pageof 15